Multidrug-resistant Tuberculosis More Widespread in Western Africa Than Previously Thought
November 13th 2016The scope of multidrug-resistant tuberculosis in West Africa, until recently, has not been well-understood, but a new study on eight countries in the region shows that the superbug is more common than previous estimates suggested.
A Preponderance of Missed Opportunities to Administer the Human Papillomavirus Vaccine
November 10th 2016Despite the Centers for Disease Control and Prevention's recommendation that the human papillomavirus (HPV) vaccine be routinely given to adolescents and young adults, administration rates for the vaccine are still low.
New Tool Can Differentiate Between Bacterial and Viral Infections
November 9th 2016Students from the University of Sheffield in the United Kingdom have developed a new diagnostic tool which promises a novel way to detect bacterial infections and prevent the inappropriate use of antibiotics for viral infections.
Study Finds that Nearly One in Four Are Infected with Latent Tuberculosis
November 9th 2016A new study from United Kingdom researchers finds that nearly one-quarter of the global population is infected with latent tuberculosis (TB), a finding that exposes the challenges ahead for the World Health Organization’s End TB Strategy.
Social Media Platforms Used for Antibiotic Stewardship Training Program
November 8th 2016Researchers at University of Chicago Medicine have created an antibiotic stewardship training program for internal medicine residents that incorporates social media platforms, offering a technological tool for a growing health problem.
ECDC Outlines Refugee Health Surveillance Practices
November 8th 2016There is a stigma that incoming refugees pose a health risk to European communities. In order to assess the risk of possible outbreaks and jump-start prevention, the European Centre for Disease Prevention and Control (ECDC) recommends implementing a multi-step Syndromic Surveillance system.
Novel Treatment for MRSA Submitted for Review to US FDA
November 7th 2016Drug maker Melinta has submitted their new antibiotic Baxdela for review by the US Food and Drug Administration, with the hopes that it will bring a new treatment option for people suffering from methicillin-resistant Staphylococcus aureus (MRSA).
WHO Report Says We're Off Target on TB Epidemic
November 7th 2016The World Health Organization (WHO) has released their Global Tuberculosis Report for 2016, emphasizing that today’s global actions and investments are falling far short of what is needed to stop the worldwide tuberculosis (TB) epidemic.